HomeIMRSQ • OTCMKTS
add
IMRIS Ord Shs
Market news
.INX
0.77%
1.33%
12.05%
0.95%
Financials
Income Statement
Revenue
Net income
(USD) | 2014info | Y/Y change |
---|---|---|
Revenue | 28.89M | — |
Operating expense | 33.07M | — |
Net income | -30.39M | — |
Net profit margin | -105.18 | — |
Earnings per share | -0.58 | 30.12% |
EBITDA | -20.30M | — |
Effective tax rate | -0.80% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | 2014info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.00M | — |
Total assets | 65.48M | — |
Total liabilities | 53.69M | — |
Total equity | 11.79M | — |
Shares outstanding | 62.59M | — |
Price to book | 0.00 | — |
Return on assets | -19.15% | — |
Return on capital | -31.61% | — |
Cash Flow
Net change in cash
(USD) | 2014info | Y/Y change |
---|---|---|
Net income | -30.39M | — |
Cash from operations | -10.91M | — |
Cash from investing | 4.49M | — |
Cash from financing | 3.50M | — |
Net change in cash | -1.38M | — |
Free cash flow | 4.58M | — |
About
IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions.
The company's flagship product is the IMRIS Surgical Theatre. A hybrid operating theatre with intraoperative imaging capabilities, The IMRIS Surgical Theatre incorporates design and technology provided by IMRIS, including the moveable intraoperative MRI, as well as technology from 3rd-party medical device companies. IMRIS designs, creates and supports the IMRIS Surgical Theatre, which the company's marketing materials describe as "the world's most advanced hybrid operating theatre." Wikipedia
Founded
2005
Headquarters
Website
Employees
121